Donor lymphocyte infusions for the treatment of chronic myelogenous leukaemia relapse following peripheral blood or bone marrow stem cell transplantation

被引：0
|
作者：
Basak, G. W.
de Wreede, L. C.
van Biezen, A.
Wiktor-Jedrzejczak, W.
Schmid, C.
Schattenberg, A.
Dazzi, F.
von dem Borne, P.
Petersen, E.
Beelen, D.
Abayomi, A.
Volin, L.
Buzyn, A.
Gurman, G.
Bunjes, D.
Olavarria, E.
de Witte, T.
机构：
来源：
BONE MARROW TRANSPLANTATION | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S307 / S307
页数：1
相关论文
共 50 条
  • [21] Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia
    Dazzi, F
    Szydlo, RM
    Cross, NCP
    Craddock, C
    Kaeda, J
    Kanfer, E
    Cwynarski, K
    Olavarria, E
    Yong, A
    Apperley, JF
    Goldman, JM
    BLOOD, 2000, 96 (08) : 2712 - 2716
  • [22] IMMUNOMODULATORY EFFECTS OF DONOR LYMPHOCYTE INFUSIONS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    SOIFFER, RJ
    ALYEA, EP
    RITZ, J
    JOURNAL OF CLINICAL APHERESIS, 1995, 10 (03) : 139 - 143
  • [23] Autologous and allogeneic peripheral blood stem cell transplantation as compared with bone marrow transplantation in children with leukaemia
    Mousavi, A
    Ghavamzadeh, A
    Hedayatiasl, A
    Shamshiri, A
    Iravani, M
    Bahar, B
    Jahani, M
    Gholibeikian, S
    Heydari, P
    Moradiseresht, M
    BONE MARROW TRANSPLANTATION, 2004, 33 : S228 - S229
  • [24] Safety and efficacy of donor lymphocyte infusions following mismatched stem cell transplantation
    Or, R.
    Hadar, E.
    Bitan, M.
    Resnick, I. B.
    Aker, M.
    Ackerstein, A.
    Samuel, S.
    Tsirigotis, P.
    Gesundheit, B.
    Slavin, S.
    Shapira, M. Y.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (12) : 1295 - 1301
  • [25] Imatinib followed by reduced intensity stem cell transplantation and donor lymphocyte infusions is effective in chronic phase chronic myeloid leukaemia
    Copland, M
    Heaney, N
    Stewart, K
    Godden, J
    Smith, G
    Crawley, C
    Holyoake, TL
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 128 - 128
  • [26] Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia
    M A Elliott
    A Tefferi
    W J Hogan
    L Letendre
    D A Gastineau
    S M Ansell
    A Dispenzieri
    M A Gertz
    S R Hayman
    D J Inwards
    M Q Lacy
    I N Micallef
    L F Porrata
    M R Litzow
    Bone Marrow Transplantation, 2006, 37 : 1003 - 1008
  • [27] KARYOTYPE AT RELAPSE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
    SHAH, NK
    WAGNER, J
    SANTOS, G
    GRIFFIN, CA
    CANCER GENETICS AND CYTOGENETICS, 1992, 61 (02) : 183 - 192
  • [28] Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia
    Elliott, M
    Tefferi, A
    Hogan, WJ
    Letendre, L
    Gastineau, DA
    Ansell, SM
    Dispenzieri, A
    Gertz, MA
    Hayman, SR
    Inwards, DJ
    Lacy, MQ
    Micallef, IN
    Porrata, LF
    Litzow, MR
    BONE MARROW TRANSPLANTATION, 2006, 37 (11) : 1003 - 1008
  • [29] AUTOLOGOUS BONE-MARROW OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE
    MELONI, G
    DEFABRITIIS, P
    ALIMENA, G
    MALAGNINO, F
    MONTEFUSCO, E
    SANDRELLI, A
    PINTO, R
    VIGNETTI, M
    LOCOCO, F
    MANDELLI, F
    BONE MARROW TRANSPLANTATION, 1989, 4 : 92 - 94
  • [30] Peripheral blood stem cells versus bone marrow in pediatric unrelated donor stem cell transplantation
    Meisel, Roland
    Klingebiel, Thomas
    Dilloo, Dagmar
    BLOOD, 2013, 121 (05) : 863 - 865
12345